Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.99 AUD | +2.64% |
|
+7.64% | -15.94% |
May. 28 | Transcript : Neuren Pharmaceuticals Limited - Shareholder/Analyst Call | |
May. 27 | Neuren Phase 2 Trial Shows Significant Improvements in Pitt Hopkins Syndrome | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.94% | 1.77B | |
+63.05% | 856B | |
+38.92% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+13.74% | 244B | |
+4.95% | 234B | |
+16.19% | 226B | |
+14.63% | 177B |
- Stock Market
- Equities
- NEU Stock
- News Neuren Pharmaceuticals Limited
- Transcript : Neuren Pharmaceuticals Limited - Special Call